A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag®

医学 体外循环 红细胞压积 体表面积 凝血因子 动脉 凝血时间激活 心脏外科 外科 麻醉 心脏病学 内科学
作者
Keith A. Samolyk,Scott R. Beckmann,Randall C. Bissinger
出处
期刊:Perfusion [SAGE Publishing]
卷期号:20 (6): 343-349 被引量:28
标识
DOI:10.1191/0267659105pf831oa
摘要

Recent data independently linking allogeneic blood use to increased morbidity and mortality after cardiopulmonary bypass (CPB) warrants the study of new methods to employ unique and familiar technology to reduce allogeneic blood exposure. The Hemobag allows the open-heart team to concentrate residual CPB circuit contents and return a high volume of autologous clotting factors and blood cells to the patient. Fifty patients from all candidates were arbitrarily selected to receive the Hemobag (HB) therapy. A retrospective control group of 50 non-Hemobag (NHB) patients were matched to the HB group patient-by-patient for comparison according to surgeon, type of procedure, age, body surface area (BSA), body weight and CPB time. Many efforts to conserve blood (Cell Saver and ANH) were employed in both groups. Post-CPB cell washing of circuit contents was additionally employed in the control group. There were no significant differences between the HB and NHB groups in regard to patient morphology, pre-op cell concentrations, distribution of surgeon or procedures (41% valve, 16% valve/coronary artery bypass graft (CABG), balance CABG), pump and ischemic times and Bayes National Risk scores. The average volume returned to the patient from the HB was 817+/-198 mL (1 SD). Average processing time was 11 min. The Hemobag contained an average platelet count of 230+/-80 K/mm3, fibrinogen concentration of 413 +/- 171 mg/dl, total protein of 8.0+/-2.8 gm/dl, albumin of 4.4+/-1.2 gm/dl and hematocrit of 43+/-7%. Factor VII, IX and X levels in three HB contents averaged 259% greater than baseline. Substantial reductions were achieved in both allogeneic blood product avoidance and cost to the hospital with use of the HB. Infusion of the Hemobag concentrate appears to recover safely substantial proteins, clotting factor and cell concentration for all types of cardiac procedures, maintaining the security of a primed circuit.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
赵振辉完成签到,获得积分10
4秒前
研零小白发布了新的文献求助10
5秒前
lily完成签到,获得积分10
7秒前
坚定的道天完成签到,获得积分10
7秒前
光亮静槐发布了新的文献求助30
9秒前
10秒前
11秒前
鱼某某完成签到,获得积分20
11秒前
Zzzzz完成签到,获得积分10
13秒前
成就的小蝴蝶完成签到,获得积分10
14秒前
15秒前
WYQ驳回了jason应助
15秒前
Wang完成签到 ,获得积分10
16秒前
理li发布了新的文献求助10
16秒前
Coldpal完成签到,获得积分10
17秒前
18秒前
18秒前
Ava应助佳妹儿采纳,获得10
19秒前
烁果累累完成签到 ,获得积分10
19秒前
ll发布了新的文献求助10
20秒前
科研通AI6应助光亮静槐采纳,获得10
20秒前
22秒前
小鲨鱼发布了新的文献求助10
22秒前
23秒前
xiaoxx91完成签到 ,获得积分10
24秒前
心信鑫发布了新的文献求助10
26秒前
26秒前
wangjue完成签到,获得积分10
27秒前
zaza驳回了酷波er应助
27秒前
小鲨鱼完成签到,获得积分10
30秒前
略略略发布了新的文献求助10
32秒前
warson发布了新的文献求助10
35秒前
liuqizong123完成签到,获得积分10
36秒前
FashionBoy应助greatzhang采纳,获得10
37秒前
38秒前
38秒前
糖糖糖唐完成签到,获得积分10
38秒前
40秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Voyage au bout de la révolution: de Pékin à Sochaux 700
First Farmers: The Origins of Agricultural Societies, 2nd Edition 500
Simulation of High-NA EUV Lithography 400
Assessment of adverse effects of Alzheimer's disease medications: Analysis of notifications to Regional Pharmacovigilance Centers in Northwest France 400
The Rise & Fall of Classical Legal Thought 260
Innovative strategies for the rapid restoration of intestinal function in patients undergoing abdominal surgery: use of probiotics. Pilot study of 15 patients 200
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4334130
求助须知:如何正确求助?哪些是违规求助? 3845506
关于积分的说明 12011639
捐赠科研通 3486091
什么是DOI,文献DOI怎么找? 1913527
邀请新用户注册赠送积分活动 956680
科研通“疑难数据库(出版商)”最低求助积分说明 857359